Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech Rival to Teva Blockbuster Said to Seek IPO
Bloomberg
Sunday, March 23, 2014 - 10:08am
tags:
Teva Pharmaceuticals, Mapi Pharma, Copaxone
Empiriko’s ‘liver in a test tube’ could speed drug development
Beta Boston, MA
Sunday, March 23, 2014 - 10:02am
tags:
Empiriko
Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Yahoo/BusinessWire
Sunday, March 23, 2014 - 9:48am
tags:
Pfizer, tofacitinib, psoriasis
Sequenom and former CFO resolve litigation
Yahoo/The Fly on the Wall
Sunday, March 23, 2014 - 9:46am
tags:
Sequenom
3 Upcoming FDA Meetings You Should be Watching
Motley Fool
Sunday, March 23, 2014 - 9:45am
tags:
EXACT Sciences, Cologuard, Pfizer, dalbavancin, Cubist Pharmaceuticals, tedizolid phosphate
Novartis chairman stresses need for R&D investment
MarketWatch
Saturday, March 22, 2014 - 1:19pm
tags:
Novartis
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
The Pharma Letter
Saturday, March 22, 2014 - 12:46pm
tags:
Takeda, vedolizumab, Entyvio, ulcerative colitis, Crohn's Disease
Genentech wins FDA approval for Xolair to treat hives
San Francisco Chronicle, CA
Saturday, March 22, 2014 - 12:19pm
tags:
Genentech, Xolair, hives
Experimental J&J psoriasis drug shows promise in study
Yahoo/Reuters
Saturday, March 22, 2014 - 12:10pm
tags:
JNJ, psoriasis, guselkumab
From Plant to Prescription: 5 Ways Marijuana Made It to the Market
Wall St Cheat Sheet
Saturday, March 22, 2014 - 11:49am
tags:
marijuana
Gilead offers Egypt new hepatitis C drug at 99 pct discount
Yahoo/Reuters
Saturday, March 22, 2014 - 11:48am
tags:
Gilead Sciences, hepatitis C, Sovaldi
The Pfizer Drama That Wasn't
Motley Fool
Saturday, March 22, 2014 - 11:44am
tags:
Pfizer
Celgene Wins U.S. Approval for Psoriatic Arthritis Pill
Bloomberg
Saturday, March 22, 2014 - 11:41am
tags:
Otezla, Celgene Corporation, psoriatic arthritis
Zogenix CEO Goes on the Offensive
Yahoo/24-7 Wallstreet
Saturday, March 22, 2014 - 11:39am
tags:
Zogenix, Zohydro, pain management
Endocyte, Merck Cancer Drug Scores Twice
investors.com
Saturday, March 22, 2014 - 11:36am
tags:
Endocyte, Merck, Vynfinit, ovarian cancer
CytRx Misled Investors According to a Recently Filed Class Action
Yahoo/PR NewsWire
Saturday, March 22, 2014 - 11:33am
tags:
CytRx, lawsuits
Biotech Tweets of the Week: Gilead Sciences and Orexigen
Motley Fool
Saturday, March 22, 2014 - 11:32am
tags:
Gilead Sciences, Orexigen
Biogen Idec CEO talks drugs in pipeline, keys to growth (video)
CNBC
Saturday, March 22, 2014 - 11:30am
tags:
Biogen Idec
Does Mannkind Offer a Good Risk to Reward Ratio?
Motley Fool
Saturday, March 22, 2014 - 11:28am
tags:
MannKind
Biotechs, Medicals Get Hurt Amid Price-Inquiry News
investors.com
Saturday, March 22, 2014 - 11:26am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.